Therapeutic potential of selective PDE inhibitors in asthma

被引:43
作者
Schudt, C [1 ]
Gantner, F [1 ]
Tenors, H [1 ]
Hatzelmann, A [1 ]
机构
[1] BYK Gulden Lomberg GmbH, Dept Biochem, D-78403 Constance, Germany
关键词
D O I
10.1006/pupt.1999.0182
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:123 / 129
页数:7
相关论文
共 48 条
[1]  
Barnette MS, 1996, BIOCHEM PHARMACOL, V51, P949
[2]  
BOCHERT G, 1994, MOL CELL BIOL, V132, P57
[3]   RECENT PROGRESS IN UNDERSTANDING THE HORMONAL-REGULATION OF PHOSPHODIESTERASES [J].
CONTI, M ;
NEMOZ, G ;
SETTE, C ;
VICINI, E .
ENDOCRINE REVIEWS, 1995, 16 (03) :370-389
[4]   INVESTIGATION INTO THE ROLE OF PHOSPHODIESTERASE-IV IN BRONCHORELAXATION, INCLUDING STUDIES WITH HUMAN BRONCHUS [J].
CORTIJO, J ;
BOU, J ;
BELETA, J ;
CARDELUS, I ;
LLENAS, J ;
MORCILLO, E ;
GRISTWOOD, RW .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (02) :562-568
[5]   Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) [J].
Degerman, E ;
Belfrage, P ;
Manganiello, VC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6823-6826
[6]  
DONGMIN MA, 1999, MOL PHARMACOL, V55, P50
[7]  
Ekholm D, 1997, J IMMUNOL, V159, P1520
[8]   Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant [J].
Erdogan, S ;
Houslay, MD .
BIOCHEMICAL JOURNAL, 1997, 321 :165-175
[9]  
Essayan DM, 1997, J PHARMACOL EXP THER, V282, P505
[10]   In vitro differentiation of human monocytes to macrophages: Change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors [J].
Gantner, F ;
Kupferschmidt, R ;
Schudt, C ;
Wendel, A ;
Hatzelmann, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (02) :221-231